News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Pfizer will let go of 150 employees at its Sanford, US site that were involved in the development of a gene therapy for Duchenne muscular dystrophy that recently failed in a phase 3 clinical trial.
AIRNA plans to bring RNA editing therapies to the clinic starting with a treatment for the genetic disease alpha-1 antitrypsin deficiency.
Results from a phase 2b clinical trial in the UK have shown that Novo Nordisk’s GLP-1 drug liraglutide can protect the brain against dementia.
Ann Graham changed the direction of her career after being treated for osteocarcoma - a type of cancer that usually affects children and young people.
The Bateman Horne Center of Excellence (BHC) has established itself as a trusted leader in the clinical care, provider education, patient advocacy, and research of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long COVID.